Sage Journals: Discover world-class research

Open access

Research article

First published 2024

Effects of omalizumab on lung function in patients with moderate-to-severe allergic asthma: a systematic review and meta-analysis

Junyi Liao, Jia Tang, Yuanping Jiang [...]

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2022-11

Phenotypes of Allergic Asthma: Does In-Vitro Allergy Testing Help Predict Asthma Disease Severity?

Michael S. Benninger, Claudia I. Cabrera, Eulalia M. Amador [...]

American Journal of Rhinology & Allergy

Retricted access

Research article

First published 2016-5

Investigation of Asthma Comorbidity in Children with Different Severities of Allergic Rhinitis

Mahmut Dogru

American Journal of Rhinology & Allergy

Retricted access

Research article

First published 2009-10

Adding Omalizumab to the Therapy of Adolescents With Persistent Uncontrolled Moderate—Severe Allergic Asthma

M. Massanari, H. Milgrom, S. Pollard [...]

Clinical Pediatrics

Free access

Research article

First published 2012-4

Omalizumab Modulates Bronchial Reticular Basement Membrane Thickness and Eosinophil Infiltration in Severe Persistent Allergic Asthma Patients

A.M. Riccio, R.W. Dal Negro, C. Micheletto [...]

International Journal of Immunopathology and Pharmacology

Open access

Review article

First published 2012

Omalizumab: Clinical Use for the Management of Asthma

Neil C. Thomson, Rekha Chaudhuri

Therapeutic Advances in Pulmonary and Critical Care Medicine

Free access

Review article

First published 2017-2

Targeting patients with asthma for omalizumab therapy: choosing the right patient to get the best value for money

Abir Al Said, Breda Cushen, Richard W Costello

Sage Open Chronic Disease

Open access

Research article

First published 2020

Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma

Nicola Lombardo, Corrado Pelaia, Marco Ciriolo [...]

International Journal of Immunopathology and Pharmacology

Open access

Review article

First published 2018

Omalizumab,the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness

Corrado Pelaia, Cecilia Calabrese, Rosa Terracciano [...]

Therapeutic Advances in Respiratory Disease

Open access

Review article

First published 2019

Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review

Giorgio Lorenzo Colombo, Sergio Di Matteo, Chiara Martinotti [...]

Therapeutic Advances in Respiratory Disease

Search results